Azd-1222/nirmatrelvir+ritonavir/tozinameranRebounds of COVID-19 and lack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1940卷 / 1期

关键词：

D O I：

10.1007/s40278-023-31960-z

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：102 / 102

相关论文

共 50 条

[1] AZD-1222/paracetamolAutoimmune encephalitis and lack of efficacy: case report
Reactions Weekly, 2022, 1888 (1) : 94 - 94
[2] AZD-1222/ApixabanThrombotic thrombocytopenia and lack of efficacy: case report
Reactions Weekly, 2025, 2040 (1) : 156 - 156
[3] AZD-1222/fexofenadineUrticarial vasculitis and lack of efficacy: case report
Reactions Weekly, 2022, 1918 (1) : 93 - 93
[4] AZD-1222/fondaparinux sodiumThrombotic thrombocytopenia and lack of efficacy: case report
Reactions Weekly, 2021, 1871 (1) : 86 - 86
[5] AZD-1222/immune globulinImmune thrombocytopenia and lack of efficacy: case report
Reactions Weekly, 2022, 1909 (1) : 124 - 124
[6] Azd-1222/immune-globulinQuadriparesis and lack of efficacy: case report
Reactions Weekly, 2022, 1923 (1) : 94 - 94
[7] Aciclovir/AZD-1222/methylprednisoloneTransverse myelitis and lack of efficacy: case report
Reactions Weekly, 2022, 1914 (1) : 19 - 19
[8] AZD-1222/immune globulinVarious toxicities and lack of efficacy: case report
Reactions Weekly, 2021, 1885 (1) : 101 - 101
[9] Azd-1222/pregabalinMultiple sclerosis relapse and lack of efficacy: case report
Reactions Weekly, 2023, 1957 (1) : 85 - 85
[10] Azd-1222/tozinameranLack of efficacy: case report
Reactions Weekly, 2023, 1938 (1) : 296 - 296

← 1 2 3 4 5 →